Purdue Pharma LP - Company Profile

Powered by

All the sales intelligence you need on Purdue Pharma LP in one solution.

$ $295
Register your interest Learn more
  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Purdue Pharma LP fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Purdue Pharma LP.

Back to companies

Purdue Pharma LP: Patents

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

View up-to-date information on Purdue Pharma LP patents, including inventor and filing insights.

Patent Trends

Publication Identifier Document Type Title Classification-CPC Publication Date
US11834447B2 Grant Indole derivatives and use thereof C07D401/04; C07D403/04; C07D403/14; C07D405/04; C07D413/14; C07D417/14 December 05, 2023
US11826472B2 Grant Tamper resistant dosage forms A61J3/005; A61J3/06; A61J3/10; A61K31/485; A61K45/06; A61K47/10; A61K47/34; A61K9/0002; A61K9/0053; A61K9/1641; A61K9/2013; A61K9/2018; A61K9/2027; A61K9/2031; A61K9/2054; A61K9/2072; A61K9/2077; A61K9/209; A61K9/2095; A61K9/28; A61K9/284; A61K9/2853; A61K9/2866; A61K9/2893; B29B7/02; B29B7/88; B29C2035/046; B29C2035/1658; B29C35/045; B29C35/16; B29C37/0025; B29C43/003; B29C43/02; B29C43/52; B29C71/00; B29C71/009; B29K2071/02; B29K2105/0035; B29K2105/251; B29K2995/0088; B29L2031/753 November 28, 2023
US20230365578A1 Application Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone A61K31/485; A61K9/14; A61K9/20; A61K9/2095; A61K9/48; A61K9/4833; C07D489/02; C07D489/04; C07D489/08 November 16, 2023
CA3084035C Grant Sleep disorder treatment and prevention A61K31/138; A61K31/145; A61K31/16; A61K31/197; A61K31/485; A61K31/498; A61K31/554; A61K31/7048; A61K45/06; A61K9/0053; A61K9/0056; A61K9/006; A61K9/2054; A61P25/20; A61P25/32 October 24, 2023
US11786463B2 Grant Pharmaceutical compositions for the treatment of ophthalmic conditions A61K31/07; A61K31/352; A61K31/355; A61K31/5377; A61K47/02; A61K47/10; A61K47/26; A61K47/44; A61K9/0014; A61K9/0019; A61K9/0048; A61K9/06; A61K9/107; A61K9/1075; A61P27/04; A61P27/06; A61P29/00 October 17, 2023
Gain a 360-degree view of and make more informed decisions for your business Gain a 360-degree view of and make more informed decisions for your business Learn more

Top Inventors by Filings (Count by publication)

Name Count
Identify the top inventors associated with your target company when you unlock full profile Identify the top inventors associated with your target company when you unlock full profile Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer